PL1803447T3 - Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka - Google Patents

Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka

Info

Publication number: PL1803447T3
Authority: PL; Poland
Prior art keywords: hydralazine; support; pharmaceutical composition; sustained release; cancer treatment
Prior art date: 2004-09-09

Application number

PL04774809T

Other languages

English (en)

Inventor

Flores Luis Estrada

González Alfonso Dueñas

GARCÍA Arturo BORBOLLA

Martínez Raúl Serna

HERNÁNDEZ Alfredo RIVERA

Betancourt Alejandro Mohar

Original Assignee

Psicofarma S A De C V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-09

Filing date

2004-09-09

Publication date

2010-05-31

2004-09-09 Application filed by Psicofarma S A De C V filed Critical Psicofarma S A De C V

2010-05-31 Publication of PL1803447T3 publication Critical patent/PL1803447T3/pl

Links

RPTUSVTUFVMDQK-UHFFFAOYSA-N Hidralazin Chemical compound C1=CC=C2C(NN)=NN=CC2=C1 RPTUSVTUFVMDQK-UHFFFAOYSA-N 0.000 title 2
206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
229960002474 hydralazine Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000013268 sustained release Methods 0.000 title 1
239000012730 sustained-release form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

PL04774809T 2004-09-09 2004-09-09 Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka PL1803447T3 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/MX2004/000064 WO2006028362A1 (es)	2004-09-09	2004-09-09	Composición farmacéutica de liberación prolongada de hidralazina y su uso como apoyo para el tratamiento del cáncer
EP04774809A EP1803447B1 (en)	2004-09-09	2004-09-09	Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Publications (1)

Publication Number	Publication Date
PL1803447T3 true PL1803447T3 (pl)	2010-05-31

Family

ID=36036613

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04774809T PL1803447T3 (pl)	2004-09-09	2004-09-09	Kompozycja farmaceutyczna do długotrwałego uwalniania hydralazyny oraz jej zastosowanie wspomagające w leczeniu raka

Country Status (17)

Country	Link
US (1)	US7820200B2 (pl)
EP (1)	EP1803447B1 (pl)
JP (1)	JP4814885B2 (pl)
CN (1)	CN101039661A (pl)
BR (1)	BRPI0419032B8 (pl)
CA (1)	CA2579220C (pl)
CR (1)	CR9035A (pl)
CY (1)	CY1110508T1 (pl)
DE (1)	DE602004022205D1 (pl)
DK (1)	DK1803447T3 (pl)
ES (1)	ES2330227T3 (pl)
MX (1)	MX2007002871A (pl)
NZ (1)	NZ554360A (pl)
PL (1)	PL1803447T3 (pl)
PT (1)	PT1803447E (pl)
SI (1)	SI1803447T1 (pl)
WO (1)	WO2006028362A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW201618783A (zh)	2014-08-07	2016-06-01	艾森塔製藥公司	以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK150008C (da)	1981-11-20	1987-05-25	Benzon As Alfred	Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US4521402A (en) *	1983-01-03	1985-06-04	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of hydrazine
US4461759A (en) *	1983-01-03	1984-07-24	Verex Laboratories, Inc.	Constant release rate solid oral dosage formulations of veropamil
IE58110B1 (en)	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
GB8624213D0 (en) *	1986-10-09	1986-11-12	Sandoz Canada Inc	Sustained release pharmaceutical compositions
EP1169024B1 (en) *	1999-03-31	2005-12-21	Janssen Pharmaceutica N.V.	Pregelatinized starch in a controlled release formulation
US20030091630A1 (en) *	2001-10-25	2003-05-15	Jenny Louie-Helm	Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20050226926A1 (en) *	2002-07-25	2005-10-13	Pfizer Inc	Sustained-release tablet composition of pramipexole
AU2003301654A1 (en) *	2002-10-22	2004-05-13	Dainippon Pharmaceutical Co., Ltd.	Stabilized composition

2004
- 2004-09-09 DE DE602004022205T patent/DE602004022205D1/de not_active Expired - Lifetime
- 2004-09-09 BR BRPI0419032A patent/BRPI0419032B8/pt not_active IP Right Cessation
- 2004-09-09 JP JP2007531093A patent/JP4814885B2/ja not_active Expired - Lifetime
- 2004-09-09 EP EP04774809A patent/EP1803447B1/en not_active Expired - Lifetime
- 2004-09-09 DK DK04774809T patent/DK1803447T3/da active
- 2004-09-09 SI SI200431198T patent/SI1803447T1/sl unknown
- 2004-09-09 ES ES04774809T patent/ES2330227T3/es not_active Expired - Lifetime
- 2004-09-09 PL PL04774809T patent/PL1803447T3/pl unknown
- 2004-09-09 CN CNA2004800439530A patent/CN101039661A/zh active Pending
- 2004-09-09 US US11/575,016 patent/US7820200B2/en not_active Expired - Lifetime
- 2004-09-09 PT PT04774809T patent/PT1803447E/pt unknown
- 2004-09-09 WO PCT/MX2004/000064 patent/WO2006028362A1/es not_active Ceased
- 2004-09-09 CA CA2579220A patent/CA2579220C/en not_active Expired - Lifetime
- 2004-09-09 NZ NZ554360A patent/NZ554360A/en not_active IP Right Cessation
2007
- 2007-03-09 MX MX2007002871A patent/MX2007002871A/es active IP Right Grant
- 2007-04-09 CR CR9035A patent/CR9035A/es not_active Application Discontinuation
2009
- 2009-10-13 CY CY20091101053T patent/CY1110508T1/el unknown

Also Published As

Publication number	Publication date
CA2579220C (en)	2013-01-08
SI1803447T1 (sl)	2010-01-29
BRPI0419032B1 (pt)	2019-02-05
CA2579220A1 (en)	2006-03-16
JP2008512450A (ja)	2008-04-24
DK1803447T3 (da)	2009-10-12
BRPI0419032A (pt)	2007-12-11
EP1803447A1 (en)	2007-07-04
CY1110508T1 (el)	2015-04-29
NZ554360A (en)	2009-11-27
MX2007002871A (es)	2007-04-23
PT1803447E (pt)	2009-08-14
BRPI0419032B8 (pt)	2021-05-25
US20090042889A1 (en)	2009-02-12
CN101039661A (zh)	2007-09-19
WO2006028362A1 (es)	2006-03-16
EP1803447B1 (en)	2009-07-22
DE602004022205D1 (de)	2009-09-03
JP4814885B2 (ja)	2011-11-16
ES2330227T3 (es)	2009-12-07
US7820200B2 (en)	2010-10-26
CR9035A (es)	2009-03-27

Similar Documents

Publication	Publication Date	Title
EP1793803A4 (en)	2009-09-23	SUSTAINED RELEASE MEDICINAL COMPOSITIONS WHICH CAN BE APPROPRIATELY IMPLANTED
EP1940361A4 (en)	2011-03-02	PHARMACEUTICAL DOSAGE FORMS HAVING CONTROLLED AND / OR IMMEDIATE RELEASE PROPERTIES
IL188964A0 (en)	2008-08-07	Sustained drug release composition
IL189364A0 (en)	2008-06-05	Estrogen compositions and therapeutic methods of use thereof
IL184735A0 (en)	2007-12-03	Pharmaceutical formulations and methods of use
IL184008A0 (en)	2007-10-31	4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
EP1895991A4 (en)	2012-11-07	MODIFIED RELEASE FORMULATIONS OF ANTI-IRRITABLE DRUGS
EP1757282A4 (en)	2010-02-10	USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
EP1753405A4 (en)	2008-09-17	SLOW RELEASE PHARMACEUTICAL PREPARATION
PL1803456T3 (pl)	2015-08-31	Kompozycje farmaceutyczne zawierające L-733060 do zastosowania w leczeniu guzów nowotworowych
LT2340872T (lt)	2017-09-11	Naujos farmacinės kompozicijos, naudingos nemigos gydyme
EP1954800A4 (en)	2010-03-03	COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
EP1928247A4 (en)	2009-10-28	COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
PT1803447E (pt)	2009-08-14	Composição farmacêutica para a libertação sustentada de hidralazina e seu uso como apoio para o tratamento do cancro
ZA200701578B (en)	2008-09-25	Combination anticancer therapy and pharmaceutical compositions therefore
ZA200700844B (en)	2009-07-29	Quinolone-containing medicinal composition
IL177735A0 (en)	2006-12-31	Combined pharmaceutical composition for the inhibition of the decline of cognitive functions
EP1803452A4 (en)	2009-12-23	ESTER DERIVATIVE AND ITS PHARMACEUTICAL USE THEREOF
GB0409356D0 (en)	2004-06-02	Patient support structures
IL185691A0 (en)	2008-01-06	Novel compounds derived from 5-thioxylose and therapeutic use thereof
GB0406014D0 (en)	2004-04-21	Pharmaceutical composition and use
ZA200704650B (en)	2008-12-31	4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
AP2006003706A0 (en)	2006-08-31	Controlled release pharmaceutical compositions
ZA200702597B (en)	2009-03-25	Ester derivative and pharmaceutical use thereof
HK1111167A (en)	2008-08-01	Novel compounds derived from 5-thioxylose and therapeutic use thereof